{
  "zip": "91942",
  "sector": "Healthcare",
  "fullTimeEmployees": 1,
  "longBusinessSummary": "Regen BioPharma, Inc. focuses on the development of small molecule therapies for treating cancer and autoimmune disorders in the United States. The company intends to develop small molecule NR2F6 that activates to immune cell for oncology and autoimmune diseases. The company was founded in 2012 and is based in La Mesa, California. Regen BioPharma, Inc. is a subsidiary of Bio-Matrix Scientific Group, Inc.",
  "city": "La Mesa",
  "phone": "619-702-1404",
  "state": "CA",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.regenbiopharmainc.com",
  "maxAge": 1,
  "address1": "4700 Spring Street",
  "fax": "619-330-2328",
  "industry": "Biotechnology",
  "address2": "Suite 304",
  "previousClose": 0.0038,
  "regularMarketOpen": 0.0038,
  "twoHundredDayAverage": 0.004364143,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.0038,
  "navPrice": null,
  "averageDailyVolume10Day": 239391,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.0038,
  "fiftyDayAverage": 0.013045883,
  "trailingAnnualDividendRate": null,
  "open": 0.0038,
  "averageVolume10days": 239391,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.356617,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.0032,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 351023,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 141848,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 1225215,
  "priceToSalesTrailing12Months": 1.7240927,
  "dayLow": 0.0032,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 351023,
  "fiftyTwoWeekHigh": 0.33,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.001,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.0038,
  "exchange": "PNK",
  "shortName": "REGEN BIOPHARMA INC",
  "longName": "Regen BioPharma, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "RGBPP",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_205078445",
  "uuid": "4f4ce6ba-e76b-3b1b-87a2-5449be83515b",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 50.406,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 158726000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.025,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1538265600,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -5475580,
  "trailingEps": -0.019,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.54766,
  "nextFiscalYearEnd": 1601424000,
  "mostRecentQuarter": 1561852800,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 568198371,
  "enterpriseValue": 4147092,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.0038,
  "logo_url": "https://logo.clearbit.com/regenbiopharmainc.com"
}